Movers & Shakers | GenomeWeb

Movers & Shakers

Premium

Former National Institutes of Health Director Elias Zerhouni has joined Danaher's board, the company said this week.

Zerhouni was appointed to fill a vacancy, the company said, adding that his initial term expires at the company's 2011 annual meeting.

Zerhouni was director of the NIH from 2002 to 2008. He currently is senior advisor at the Johns Hopkins University School of Medicine and is a senior fellow for the Bill and Melinda Gates Foundation Global Health Program.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.